Top Markets
Coin of the day
UnitedHealth Group Incorporated UnitedHealth Group Incorporated

UnitedHealth Group Incorporated

UNH
Classement en actions #46
UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare... UnitedHealth Group Incorporated (UNH) operates as a comprehensive healthcare enterprise across the United States, structuring its diverse services into four key divisions: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment provides a wide array of health benefit plans and consumer-focused services. These offerings cater to a broad spectrum of clients, including large national corporations, public sector employers, mid-sized and small businesses, and individual consumers. It also delivers specialized health coverage and wellness programs tailored for individuals aged 50 and older, addressing their needs for preventive and acute care, chronic disease management, and other age-specific health issues. This division further encompasses Medicaid plans, children's health insurance, dental benefits, and various hospital and clinical services. Optum Health focuses on delivering direct healthcare solutions and management services. It facilitates access to networks of specialist care providers, offers health management programs, direct care delivery, consumer engagement initiatives, and financial services. Its diverse clientele includes individuals (served directly through care systems), employers, insurance payers, and government organizations. Optum Insight specializes in providing technology, information, and consulting services to the healthcare industry. Its offerings include software and data products, advisory consulting arrangements, and outsourced managed services. Clients span hospital systems, physicians, health plans, governmental bodies, life sciences companies, and other relevant organizations. Finally, Optum Rx handles the company's pharmaceutical care services. This segment manages retail pharmacy networks, provides home prescription delivery, and offers specialty and compounding pharmacy capabilities. Leveraging its purchasing power and clinical expertise, Optum Rx also develops advanced programs related to step therapy, formulary management, medication adherence, and integrated disease and drug therapy management. UnitedHealth Group Incorporated, founded in 1977, has its corporate headquarters located in Minnetonka, Minnesota.
Prix de l'action
$374.54
Capitalisation boursière
$340.14B
Changement (1 jour)
-0.60%
Changement (1 an)
11.24%
Pays
US
Échange UnitedHealth Group Incorporated (UNH)

Catégorie

Ratio P/E pour UnitedHealth Group Incorporated (UNH)
Ratio P/E au September 2026 TTM : 24.66
Selon les derniers rapports financiers et le cours de l'action de UnitedHealth Group Incorporated, le ratio P/E actuel (TTM) est de 24.66. À la fin de l’année 2024, le P/E de l’entreprise était de 32.62.
Historique du ratio P/E pour UnitedHealth Group Incorporated de 2000 à 2026
Ratio P/E à la fin de chaque année
Année Ratio P/E Changez
2026 (TTM) 24.66 16.78%
2025 21.12 -35.27%
2024 32.62 49.45%
2023 21.83 -11.30%
2022 24.61 -10.16%
2021 27.39 27.19%
2020 21.54 6.61%
2019 20.20 0.93%
2018 20.02 -0.57%
2017 20.13 -7.29%
2016 21.71 12.58%
2015 19.29 10.29%
2014 17.49 29.85%
2013 13.47 33.60%
2012 10.08 -4.41%
2011 10.55 20.84%
2010 8.73 -6.30%
2009 9.31 -14.13%
2008 10.85 -33.89%
2007 16.41 -5.51%
2006 17.36 -31.90%
2005 25.50 19.68%
2004 21.30 2.53%
2003 20.78 10.83%
2002 18.75 -22.59%
2001 24.22 -10.39%
2000 27.03 0.00%
Ratio P/E pour des entreprises similaires ou concurrentes
Entreprise P/E Ratio Différence du P/E Ratio Pays
24.95 1.15%
US
18.86 -23.55%
US
11.96 -51.51%
US
38.26 55.12%
US
- -
US
Comment lire un P/E ratio ?

Le ratio Prix/Bénéfice (P/E Ratio) mesure la relation entre le cours de l'action d'une entreprise et ses bénéfices par action.
Un P/E bas mais positif indique une entreprise qui génère des bénéfices élevés par rapport à sa valorisation et qui pourrait être sous-évaluée. Un P/E négatif élevé (proche de 0) indique des pertes importantes.

Les entreprises avec un P/E supérieur à 30 ou négatif sont généralement considérées comme des "actions de croissance", ce qui signifie que les investisseurs s'attendent à ce qu'elles se développent ou deviennent rentables.

Les entreprises avec un P/E positif inférieur à 10 sont généralement considérées comme des "actions de valeur", car elles sont déjà très rentables mais avec peu de potentiel de croissance.